LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY

LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY

One-hundred and four adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) were treated with fractionated doses of gemtuzumab ozogamicin (GO) at one-single French center over a 10-year period. We attempted to define predictive factors for response and survival. The overall...

Full description

Saved in:
Bibliographic Details
Main Authors: Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles
Format: Article
Language:English
Published: PAGEPress Publications 2020-04-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
acute myeloid leukemia; gemtuzumab ozogamicin; prognosis; treatment
Online Access:https://mjhid.org/index.php/mjhid/article/view/4144
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mjhid.org/index.php/mjhid/article/view/4144

Similar Items